CorVent Medical gains CE mark approval for critical care ventilator

CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe.

Santa Clara, Calif.-based CorVent’s Respond-19 ventilator allows hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS). The system received FDA emergency use authorization (EUA) for primary critical care use in December 2020 amid the COVID-19 pandemic. CorVent expects full FDA clearance sometime this year.

Respond-19 offers flexible expansion of critical care ventilation and provides invasive and non-invasive respiratory support at a lower cost of ownership without traditional requirements for costly service or maintenance plans, CorVent said in a news release.

“The Respond-19 ventilator equips healthcare providers with a highly responsive fleet of ICU-quality ventilators. With a streamlined interface that can be deployed at moment’s notice, the Respond-19 ventilator al…

Read more
  • 0